CARsgen Therapeutics Holdings Ltd Ordinary Shares CRTHF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 569.83M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 45.81
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America. During the year, a majority of the Group's revenue was derived from one customer located in the Chinese mainland.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 424
- Website
- https://www.carsgen.com
Valuation
|
Metric
|
CRTHF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 6.68 |
Price/Sales | 45.81 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CRTHF
|
|---|---|
Quick Ratio | 6.98 |
Current Ratio | 7.07 |
Interest Coverage | −12.94 |
Quick Ratio
CRTHF
Profitability
|
Metric
|
CRTHF
|
|---|---|
Return on Assets (Normalized) | −2.58% |
Return on Equity (Normalized) | −4.59% |
Return on Invested Capital (Normalized) | −4.29% |
Return on Assets
CRTHF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|K&TnHG | LOCK|ljcq | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|!^x?zDk | LOCK|nfn!^ | $83B | |||
| Moderna Inc
MRNA
| LOCK|JD<TKy | LOCK|wrv | $80B | |||
| argenx SE ADR
ARGX
| LOCK|!bpd%$ | LOCK|V? | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|wk^!&S | LOCK|Hq@ | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|PG?YS# | LOCK|Pby^ | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|KS#!W<< | LOCK|^<K># | $28B | |||
| Incyte Corp
INCY
| LOCK|&KlkYP% | LOCK|@% | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|TJ&wYh | LOCK|$& | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|n#&VLzS | LOCK|Zhr | $14B |
United States